Torrent Pharmaceuticals Ltd 2019 AR2
The report highlights Torrent Pharmaceuticals Limited's performance and sustainability initiatives for the fiscal year 2018-19. The company successfully integrated the acquired Unichem India business, which became cash accretive in its first year, and achieved a 29% revenue growth to ’ 7,673 crores. On the environmental front, Torrent installed a 1 MW Solar Rooftop power plant at its Indrad facility and achieved a significant reduction in waste generation. Its flagship CSR program, REACH, screened over 58,000 children for malnutrition and anemia, while the 'Siksha Setu' program improved educational outcomes for over 8,000 children.
Company: Torrent Pharmaceuticals Ltd
Sector: Health Care
Country: India
Year: 2019
Type: AR2
Pages: 220
Torrent Pharmaceuticals Ltd
Annual Report
The report highlights Torrent Pharmaceuticals Limited's performance and sustainability initiatives for the fiscal year 2018-19. The company successfully integrated the acquired Unichem India business, which became cash accretive in its first year, and achieved a 29% revenue growth to ’ 7,673 crores. On the environmental front, Torrent installed a 1 MW Solar Rooftop power plant at its Indrad facility and achieved a significant reduction in waste generation. Its flagship CSR program, REACH, screened over 58,000 children for malnutrition and anemia, while the 'Siksha Setu' program improved educational outcomes for over 8,000 children.
Sign in for free to access detailed sustainability data, reporting standards, and ESG metrics.
Document Details
Report Year
2019
Reporting Period
Apr 1, 2018 - Mar 31, 2019
Fiscal Year
2019
Published
Jul 23, 2019
Type
Annual Report with Sustainability Disclosures
Language
English
Pages
File Size
Standards & Assurance
Materiality Assessment
ESG Data?Experimental — AI-extracted data, may contain inaccuracies
Employees